Vivos Inc., a pharmaceutical
company in the process of researching and developing minimally invasive treatments to combat cancer has developed an Yttrium-90 based brachytherapy injectable device, for the treatment of
malignant tumors in in humans (RadioGel™) and animals (IsoPet®). Brachytherapy uses highly localized radiation to
destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area using the company’s proprietary hydrogel formulation.